Transgene SA TRGNF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | -0.57% | 99.62% | |||
| Total Other Revenue | -0.59% | 9.66% | |||
| Total Revenue | -0.59% | 14.33% | |||
| Cost of Revenue | -0.59% | -3.02% | |||
| Gross Profit | 0.59% | 6.44% | |||
| SG&A Expenses | -0.59% | 17.43% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -0.55% | -83.25% | |||
| Total Operating Expenses | -0.59% | -3.86% | |||
| Operating Income | 0.59% | 6.52% | |||
| Income Before Tax | 0.59% | 13.61% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.59% | 13.61% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.59% | 13.61% | |||
| EBIT | 0.59% | 6.52% | |||
| EBITDA | 0.59% | 6.81% | |||
| EPS Basic | 0.60% | 50.74% | |||
| Normalized Basic EPS | 0.48% | 50.71% | |||
| EPS Diluted | 0.57% | 48.23% | |||
| Normalized Diluted EPS | 0.48% | 50.71% | |||
| Average Basic Shares Outstanding | 0.00% | 75.26% | |||
| Average Diluted Shares Outstanding | 0.00% | 75.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||